CongressBuys

Sen. James M. Inhofe sold CRISPR Therapeutics AG (CRSP)

Sen. James M. Inhofe (R-OK) · $1K–$15K · traded Jan 5, 2021

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
The member
Traded
Jan 5, 2021
Disclosed
Jan 15, 2021
Days to disclose
10
Asset type
Stock
As filed
CRISPR Therapeutics AG
Industry
Biotechnology · Healthcare

Recent Congress trades in CRSP

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.